AstraZeneca - 31 Year Stock Price History | AZN

Historical daily share price chart and data for AstraZeneca since 1993 adjusted for splits and dividends. The latest closing stock price for AstraZeneca as of February 29, 2024 is 64.16.
  • The all-time high AstraZeneca stock closing price was 74.17 on April 24, 2023.
  • The AstraZeneca 52-week high stock price is 76.56, which is 19.3% above the current share price.
  • The AstraZeneca 52-week low stock price is 60.47, which is 5.8% below the current share price.
  • The average AstraZeneca stock price for the last 52 weeks is 68.27.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AstraZeneca Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 65.3013 67.3653 68.5176 60.1068 64.1600 -3.27%
2023 67.0726 66.8558 74.1729 60.8963 66.3312 1.45%
2022 60.2843 54.8973 68.1113 51.1278 65.3804 19.22%
2021 51.9822 46.2944 60.0942 44.0548 54.8408 19.72%
2020 47.1538 44.8603 55.5416 34.3521 45.8087 3.20%
2019 37.3346 32.5682 44.9226 30.5779 44.3885 35.65%
2018 31.4669 29.3219 35.7475 27.8550 32.7233 13.79%
2017 26.0143 21.8985 28.8646 21.1161 28.7583 33.20%
2016 23.4669 25.2479 27.0906 20.3970 21.5903 -15.87%
2015 25.1375 25.5364 27.3548 22.8894 25.6636 0.53%
2014 25.2853 20.3811 29.0326 20.3602 25.5292 23.57%
2013 17.4057 15.8350 20.7047 15.2706 20.6595 33.15%
2012 14.7752 14.7357 16.0516 12.8941 15.5165 8.55%
2011 14.4865 13.5208 15.8750 12.6451 14.2941 6.11%
2010 13.6894 13.1417 15.6032 11.7710 13.4713 3.53%
2009 11.4170 10.6857 13.0280 8.2778 13.0114 20.46%
2008 10.9946 10.6749 12.9998 8.9772 10.8015 0.26%
2007 12.9400 13.1426 14.7039 10.7730 10.7730 -17.51%
2006 13.5265 11.9318 16.1862 10.9156 13.0597 13.28%
2005 10.2297 8.3845 11.7421 8.0372 11.5286 36.86%
2004 10.3463 11.1430 11.6926 8.3058 8.4238 -23.43%
2003 9.1505 7.7646 11.2499 6.4423 11.0020 40.85%
2002 9.0282 10.0120 11.4792 6.4891 7.8114 -23.27%
2001 10.2152 10.9325 11.1076 9.1748 10.1802 -8.00%
2000 9.2530 8.4859 11.2268 6.4991 11.0657 28.46%
1999 8.5921 9.2830 9.8786 7.2576 8.6138 -5.53%
1998 8.2325 7.2633 9.8931 6.5523 9.1184 26.70%
1997 6.1862 5.3591 7.5066 5.2775 7.1967 31.28%
1996 4.4248 3.7752 5.5797 3.6318 5.4818 47.40%
1995 3.1237 2.5315 3.9504 2.4852 3.7191 46.48%
1994 2.1909 2.1996 2.6013 1.8567 2.5389 14.65%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $202.610B $45.811B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $719.883B 119.88
Novo Nordisk (NVO) Denmark $545.415B 44.93
Johnson & Johnson (JNJ) United States $389.136B 15.49
Merck (MRK) United States $324.660B 85.46
AbbVie (ABBV) United States $314.432B 16.02
Novartis AG (NVS) Switzerland $216.666B 15.01
Pfizer (PFE) United States $152.689B 14.78
Sanofi (SNY) $121.420B 10.93
Innoviva (INVA) United States $0.984B 8.87